Saturday, 24 June 2017

Japan News

  • Sanofi to launch 20 new drugs in Japan by 2020

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2016

    Singapore: If reports are to be believed French drug giant Sanofi is all set to launch 20 new drugs in Japan by 2020. In a recently held press meet the company's CEO Mr Jacques Nathan said ...Read more

  • Japan's Fujifilm Holdings to acquire Takeda's arm?

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2016

    Singapore: If sources are to be believed, Japan's Fujifilm Holdings is all set to buy pharma giant Takeda Pharmaceutical's 70 percent stake in Wako Pure Chemical Industries for about 200 bi...Read more

  • Japanese firm invests $11.4 mn in TB and malaria research

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 Nov, 2016

    Singapore: With a view to curb the menace of malaria and tuberculosis(TB), Japan's investment firm, Global Health Innovative Technology Fund (GHIT Fund) has issued funding totaling $11.4 mi...Read more

  • Cardinal Health expands cardiovascular portfolio

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2016

    Singapore: Cardinal Health has expanded its current distribution agreement with Biosensors as the exclusive distributor for Biosensors' coronary interventional products in Japan. The comp...Read more

  • Clinigen makes foray into Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 19 Oct, 2016

    Singapore: Further building on its presence in the Asian region, Burton-based Clinigen Group,has launched its Japanese business with the opening of an office in Tokyo, Japan. Alongside the ...Read more

  • Japan's Towa Phamaceuticals to enter the US market

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 15 Nov, 2016

    Singapore: Japanese drug giant Towa Pharmaceuticals makes foray into the US markets banking on its new set of pills that can be taken without water. The tablets, manufactured with Ractab te...Read more

  • India urges Japan to provide wider pharma market access

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2016

    Singapore: The Indian commerce Minister, Ms Nirmala Sitharaman has urged Japan to provide Indian pharmaceutical sector with a wider share and greater market access in Japan. Ms Sitharaman f...Read more

  • Zydus Cadila, Takeda to co-develop vaccine for chikungunya

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 23 Sep, 2016

    Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vaccine for chikungunya. As per the terms the companies will jointly devel...Read more

  • Japan market forecast

    Japan |  Opinion | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2016

    Singapore: Japan's demographic profile will continue to create revenue earning opportunities for the pharmaceuticals and healthcare industry. Supported by an expansive universal healthcare ...Read more

  • Stem cell scientist sues Nobel laureate for deception

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013

    Singapore: Dr Rongxiang Xu, a scientist who claims to be the founder of human body regenerative restoration science, has filed a lawsuit against Dr Shinya Yamanaka, one of the winners of th...Read more

  • Niigata Univ stroke therapy license for Shimojani

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 Feb, 2013

    Singapore: Shimojani obtained exclusive license from Japan's Niigata University for worldwide development and commercialization of an invention that reduces the risk of hemorrhage in acute...Read more

  • Astellas prostrate cancer drug gets EU nod

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013

    Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer, whose disease has progressed on...Read more

  • Columbia Asia receives $101mn investment from Mitsui & Co.

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2016

    Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospi...Read more

  • Teijin, Versartis partner for commercialization of Somavaratan in Japan

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2016

    Singapore: Teijin Limited and Versartis, Inc. has announced that the companies and their wholly owned subsidiaries have entered into an exclusive license and supply agreement for the develo...Read more

  • Tivozanib shows superiority over sorafenib in trial

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 18 May, 2012

    Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS superiority versus approved targeted agent sorafenib in advanced Renal ...Read more

  • Chugai gets positive outcome from Actemra Subcutaneous Injection trials

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016

    Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemra), the humanized antihuman IL-6 receptor monoclonal antibody, succes...Read more

  • Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016

    Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Pharmaceutical Company Limited, to conduct a feasibility study for the ...Read more

  • Histogenics to develop Purpose's NeoCart for Japanese Market

    Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 May, 2016

    Histogenics Corporation, a NASDAQ-listed regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced that it has acquired the de...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls